Page 240 - Environmental Nanotechnology Applications and Impacts of Nanomaterials
P. 240

Principles and Procedures to Assess Nanomaterial Toxicity  225

        Online Data Bank
        With an increasing number of NM being produced, it is essential that
        the scientific community have an easily accessible data bank. This online
        bank should hold safety information of all NM already tested and provide
        frequent updates on NM in the process of being tested. This format is
        already in use by the Hazardous Substances Data Bank (HSDB), which
        can be accessed at www.nlm.nih.gov/pubs/factsheets/hsdbfs.html. Another
        example is the protein data bank (PDB) found at www.rcsb.org/pdb. With
        these formats in mind, many different modes of information about NM,
        such as NM characterization, laboratory methods, environmental
        fate/exposure, safety and handling, in vitro studies, in vivo studies, and
        human health effects, can be provided to the interested party. This type
        of data bank promotes standardization and allows open access to up-to-
        date information. It is essential that we use these methods when com-
        municating with a worldwide audience, especially given the rapid growth
        in the number of new NM.
          Once a NM database has been established, the scientific community
        can further refine the material characteristics leading to toxicity (e.g.,
        size/charge or hydrophobicity). It will also be possible to work with
        batches of NM to develop a toxicological grading system.
          In summary, the demand for a predictive and pragmatic approach to
        nanotoxicity is compelling. While it is optimal to collect data at differ-
        ent tiers of toxicity, some flexibility is required to develop decision
        matrixes for in vitro and in vivo testing. Ultimately, the goal of the pre-
        dictive approach would be to develop a series of toxicity assays that limit
        the demand for large-scale in vivo studies, both from a cost as well as
        an animal-use perspective. It is important to mention the potential
        significant difficulties that may be encountered in conducting in vitro
        and in vivo studies with engineered NM. This has largely to do with lack
        of knowledge of real-world exposures to NM, including dosage, com-
        plexity of working/living environment, aggregation status, and so on.
        As nanotechnology develops, it is essential that the toxicological
        approach also evolves and stays up to date. This will provide an impor-
        tant safeguard for the continued expansion of the nanotechnology
        industry.


        Abbreviations
        ARE, antioxidant response element; ESR, electron spin resonance;
        GPx, glutathione peroxidese; GSH, glutathione; GSSG, glutathione
        disulfide; GST, glutathione S-transferase; JNK, NH -terminal Jun
                                                           2
        kinase; HO-1, heme oxygenase 1; MAPK, mitogen-activated protein
                                        –
        kinase; NAC, N-acetylcysteine; O , superoxide; OH, hydroxyl radical;
                                       2
        PM, particle matter; PT, permeability transition; ROS, reactive oxygen
   235   236   237   238   239   240   241   242   243   244   245